Abstract

Lipopolysacharide (LPS) pre-conditioning (PC), has been shown to exert protective effects against cytotoxic effects. Therefore, we hypothesized, the tolerance produced by LPS PC will be resulted by the alterations and modifications in gene and protein expression. With reference to the results of MTT assays, AO/PI staining, and Annexin V-FITC analyses of LPS concentration (0.7815–50 μg/mL) and time-dependent (12–72 h) experiments, the pre-exposure to 3 μg/mL LPS for 12 h protected the differentiated PC12 cells against 0.75 mg/mL LPS apoptotic concentration. LPS-treated cells secreted more inflammatory cytokines like IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-6, IL-17, IFN-γ, and TNF-α than LPS-PC cells. The production of inflammatory mediators ROS and NO was also higher in the LPS-induced cells compared to LPS-PC cells. Conversely, anti-inflammatory cytokines (like IL-10, IL-13, CNTF, and IL-1Ra) were upregulated in the LPS-PC cells but not in the LPS-induced cells. Meanwhile, the LPS initiated caspase-8 which in turn activates effector caspase 3/7. When the activities of caspases in the LPS-induced cells were inhibited using z-VADfmk and z-DEVDfmk, the expressions of c-MYC and Hsp70 were increased, but p53 was reduced. The potential molecules associated with protective and destructive effect was measured by RT2 Profiler PCR array to elucidate the signaling pathways and suggested inhibition NF-κB/caspase-3 signaling pathway regulates the cytoprotective genes and proto-oncogenes. In conclusion, this study provides a basis for future research to better understand the molecular mechanism underlying LPS pre-conditioning /TLR4 pre-activation and its functional role in offering cytoprotective response in neuronal environment.

Highlights

  • Brain diseases remain a clinical problem as we have incomplete understanding of their pathogenesis

  • In order to achieve that, the goals of our research were (1) to optimize the concentration and the exposure duration of LPS pre-conditioning that will induce protection against apoptosis in differentiated PC12 cells, (2) to investigate the effect of LPS preconditioning on the expression and/or production of cytokines, chemokines, reactive oxygen species (ROS), nitric oxide (NO), as well as pro-apoptotic proteins and genes, and (3) to elucidate the downstream signaling pathway involved in LPS-induced responses in in vitro differentiated PC12 cells

  • The present study evaluated the concentration and time period which confer cytoprotective potential of LPS pre-conditioning against apoptosis in differentiated PC12 cells

Read more

Summary

Introduction

Brain diseases remain a clinical problem as we have incomplete understanding of their pathogenesis. Cerebral ischemia after cardiac arrest, focal occlusion of the brain vessel, traumatic brain injury and ischemia brain damage after cardiac or brain surgery causes adult disability and death of millions of people worldwide (Feigin et al, 2010). The brain has long been deliberated as an immune-privileged site because of the presence of blood brain barrier (BBB) and the deficiency of the lymphatic system is capable of inflammatory response. Invading pathogens, trauma, and infections trigger glial cells to secrete reactive oxygen species (ROS)/ reactive nitrogen species (RNS) inflammatory mediators and neurotoxic free radicals, which may contribute to brain inflammation or neuroinflammation. Emerging evidence indicates that neuroinflammation is closely associated with neurodegenerative diseases. Regulation of neuroinflammation is essential to maintain the environment in nervous tissue and prevent the onset of neurodegenerative diseases

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.